PE Tech Report


Like this article?

Sign up to our free newsletter

Qiming promotes Nisa Leung to managing partner

Qiming Venture Partners has promoted Nisa Leung to managing partner effective immediately.

Leung (pictured) joined Qiming as a venture partner in 2006 to head the firm’s healthcare practice. She currently sits on the board of Gan & Lee Pharmaceutical, Novast Pharmaceuticals, Crown Bioscience, Sangon Biotech, Nurotron, Goodwill Information Technology, Origene Technologies and has represented Qiming on other healthcare investments including CITIC Pharmaceuticals and Aeonmed Medical among others.
Leung joins Duane Kuang, JP Gan, Hans Tung, and Gary Rieschel as managing partners of Qiming Venture Partners.
“Nisa has spent the last 13 years building, operating, and investing in healthcare technologies and services in China and has become a leading presence in this industry in China,” says Rieschel. “We are delighted to have her as a member of our leadership team.”

Like this article? Sign up to our free newsletter




Blackstone Private Equity